Suppr超能文献

CT 预测新辅助治疗后胰腺癌切缘阴性切除:系统评价和荟萃分析。

CT in the prediction of margin-negative resection in pancreatic cancer following neoadjuvant treatment: a systematic review and meta-analysis.

机构信息

Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, South Korea.

Department of Radiology, Pusan National University Hospital and Pusan National University School of Medicine, Busan, 49241, South Korea.

出版信息

Eur Radiol. 2021 May;31(5):3383-3393. doi: 10.1007/s00330-020-07433-0. Epub 2020 Oct 30.

Abstract

OBJECTIVES

We aimed to systematically evaluate the diagnostic accuracy of CT-determined resectability following neoadjuvant treatment for predicting margin-negative resection (R0 resection) in patients with pancreatic ductal adenocarcinoma (PDAC).

METHODS

Original studies with sufficient details to obtain the sensitivity and specificity of CT-determined resectability following neoadjuvant treatment, with a reference on the pathological margin status, were identified in PubMed, EMBASE, and Cochrane databases until February 24, 2020. The identified studies were divided into two groups based on the criteria of R0 resectable tumor (ordinary criterion: resectable PDAC alone; extended criterion: resectable and borderline resectable PDAC). The meta-analytic summary of the sensitivity and specificity for each criterion was estimated separately using a bivariate random-effect model. Summary results of the two criteria were compared using a joint-model bivariate meta-regression.

RESULTS

Of 739 studies initially searched, 6 studies (6 with ordinary criterion and 5 with extended criterion) were included for analysis. The meta-analytic summary of sensitivity and specificity was 45% (95% confidence interval [CI], 19-73%; I = 88.3%) and 85% (95% CI, 65-94%; I = 60.5%) for the ordinary criterion, and 81% (95% CI, 71-87%; I = 0.0%) and 42% (95% CI, 28-57%; I = 6.2%) for the extended criterion, respectively. The diagnostic accuracy significantly differed between the two criteria (p = 0.02).

CONCLUSIONS

For determining resectability on CT, the ordinary criterion might be highly specific but insensitive for predicting R0 resection, whereas the extended criterion increased sensitivity but would decrease specificity. Further investigations using quantitative parameters may improve the identification of R0 resection.

KEY POINTS

• CT-determined resectability of PDAC after neoadjuvant treatment using the ordinary criterion shows low sensitivity and high specificity in predicting R0 resection. • With the extended criterion, CT-determined resectability shows higher sensitivity but lower specificity than with the ordinary criterion. • CT-determined resectability with both criteria achieved suboptimal diagnostic performances, suggesting that care should be taken while selecting surgical candidates and when determining the surgical extent after neoadjuvant treatment in patients with PDAC.

摘要

目的

本研究旨在系统评估新辅助治疗后 CT 确定的可切除性对预测胰腺导管腺癌(PDAC)患者边缘阴性切除(R0 切除)的诊断准确性。

方法

在 PubMed、EMBASE 和 Cochrane 数据库中检索到了 2020 年 2 月 24 日之前具有足够详细信息以获取新辅助治疗后 CT 确定的可切除性的敏感性和特异性的原始研究,并参考病理切缘状态。根据 R0 可切除肿瘤的标准(普通标准:单独可切除 PDAC;扩展标准:可切除和边缘可切除 PDAC)将这些研究分为两组。使用双变量随机效应模型分别估计每个标准的敏感性和特异性的荟萃分析总结。使用联合模型双变量荟萃回归比较两个标准的汇总结果。

结果

最初搜索了 739 项研究,其中 6 项研究(6 项普通标准和 5 项扩展标准)纳入分析。普通标准的敏感性和特异性的荟萃分析总结分别为 45%(95%置信区间 [CI],19-73%;I=88.3%)和 85%(95% CI,65-94%;I=60.5%),扩展标准分别为 81%(95% CI,71-87%;I=0.0%)和 42%(95% CI,28-57%;I=6.2%)。两个标准之间的诊断准确性有显著差异(p=0.02)。

结论

对于 CT 确定的 PDAC 可切除性,普通标准可能具有高度特异性但对预测 R0 切除的敏感性较低,而扩展标准则增加了敏感性但降低了特异性。使用定量参数的进一步研究可能会提高对 R0 切除的识别。

重点

• 新辅助治疗后使用普通标准的 CT 确定的 PDAC 可切除性预测 R0 切除的敏感性低而特异性高。• 使用扩展标准,CT 确定的可切除性比普通标准具有更高的敏感性但更低的特异性。• 两种标准的 CT 确定的可切除性均表现出不理想的诊断性能,因此在选择手术候选者和确定新辅助治疗后 PDAC 患者的手术范围时应谨慎。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验